Arrayit Corporation Announces Microarray Platform Sale To Leading Laboratory In Israel
Published: Nov 22, 2013
SUNNYVALE, Calif.--(BUSINESS WIRE)--Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces today that the Company has sold a $129,548 NanoPrint™ LM60 Enterprise Level Microarray Printer to a leading research laboratory in Tel Aviv, Israel. Arrayit NanoPrint™ instruments enable microarray manufacturing in a high-throughput and highly automated manner using advanced linear drive motion control and linear encoders that permit nanometer positional resolution. Microarrays are biomedical devices that contain genes, proteins, antibodies and other molecules from the human genome and proteome printed at high-density on glass substrates. Patient samples are labeled and reacted with microarrays to provide answers to human health including the pre-symptomatic detection of cancer, autoimmune disease, and other treatable conditions.
Help employers find you! Check out all the jobs and post your resume.